vs

Side-by-side financial comparison of GERON CORP (GERN) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $31.4M, roughly 1.5× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -39.0%, a 75.3% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 37.6%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 23.7%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

GERN vs PDLB — Head-to-Head

Bigger by revenue
GERN
GERN
1.5× larger
GERN
$47.2M
$31.4M
PDLB
Growing faster (revenue YoY)
GERN
GERN
+29.4% gap
GERN
67.1%
37.6%
PDLB
Higher net margin
PDLB
PDLB
75.3% more per $
PDLB
36.3%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
23.7%
PDLB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
PDLB
PDLB
Revenue
$47.2M
$31.4M
Net Profit
$-18.4M
$10.1M
Gross Margin
Operating Margin
-29.4%
43.6%
Net Margin
-39.0%
36.3%
Revenue YoY
67.1%
37.6%
Net Profit YoY
30.3%
245.6%
EPS (diluted)
$-0.03
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
PDLB
PDLB
Q4 25
$31.4M
Q3 25
$47.2M
$26.7M
Q2 25
$49.0M
$26.5M
Q1 25
$39.6M
$24.6M
Q4 24
$22.8M
Q3 24
$28.3M
$20.2M
Q2 24
$882.0K
$20.2M
Q1 24
$304.0K
$20.5M
Net Profit
GERN
GERN
PDLB
PDLB
Q4 25
$10.1M
Q3 25
$-18.4M
$6.5M
Q2 25
$-16.4M
$6.1M
Q1 25
$-19.8M
$6.0M
Q4 24
$2.9M
Q3 24
$-26.4M
$2.4M
Q2 24
$-67.4M
$3.2M
Q1 24
$-55.4M
$2.4M
Operating Margin
GERN
GERN
PDLB
PDLB
Q4 25
43.6%
Q3 25
-29.4%
32.8%
Q2 25
-25.4%
30.2%
Q1 25
-42.2%
32.5%
Q4 24
19.6%
Q3 24
-99.8%
15.2%
Q2 24
-7860.9%
21.8%
Q1 24
-18465.1%
18.3%
Net Margin
GERN
GERN
PDLB
PDLB
Q4 25
36.3%
Q3 25
-39.0%
24.3%
Q2 25
-33.4%
23.0%
Q1 25
-50.1%
24.2%
Q4 24
14.1%
Q3 24
-93.5%
12.1%
Q2 24
-7639.8%
15.8%
Q1 24
-18220.4%
11.8%
EPS (diluted)
GERN
GERN
PDLB
PDLB
Q4 25
$0.43
Q3 25
$-0.03
$0.27
Q2 25
$-0.02
$0.25
Q1 25
$-0.03
$0.25
Q4 24
$0.11
Q3 24
$-0.04
$0.10
Q2 24
$-0.10
$0.14
Q1 24
$-0.09
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
PDLB
PDLB
Cash + ST InvestmentsLiquidity on hand
$78.1M
$126.2M
Total DebtLower is stronger
$596.1M
Stockholders' EquityBook value
$248.7M
$541.5M
Total Assets
$567.4M
$3.2B
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
PDLB
PDLB
Q4 25
$126.2M
Q3 25
$78.1M
$146.6M
Q2 25
$77.7M
$126.6M
Q1 25
$83.7M
$129.9M
Q4 24
$139.8M
Q3 24
$60.3M
$155.8M
Q2 24
$116.9M
$103.2M
Q1 24
$189.8M
$134.7M
Total Debt
GERN
GERN
PDLB
PDLB
Q4 25
$596.1M
Q3 25
$521.1M
Q2 25
$536.1M
Q1 25
$521.1M
Q4 24
$596.1M
Q3 24
$580.4M
Q2 24
$680.4M
Q1 24
$680.4M
Stockholders' Equity
GERN
GERN
PDLB
PDLB
Q4 25
$541.5M
Q3 25
$248.7M
$529.8M
Q2 25
$259.5M
$521.1M
Q1 25
$268.2M
$513.9M
Q4 24
$505.5M
Q3 24
$292.3M
$504.6M
Q2 24
$306.7M
$497.7M
Q1 24
$344.9M
$493.7M
Total Assets
GERN
GERN
PDLB
PDLB
Q4 25
$3.2B
Q3 25
$567.4M
$3.2B
Q2 25
$555.2M
$3.2B
Q1 25
$562.5M
$3.1B
Q4 24
$3.0B
Q3 24
$444.9M
$3.0B
Q2 24
$449.4M
$2.8B
Q1 24
$482.1M
$2.8B
Debt / Equity
GERN
GERN
PDLB
PDLB
Q4 25
1.10×
Q3 25
0.98×
Q2 25
1.03×
Q1 25
1.01×
Q4 24
1.18×
Q3 24
1.15×
Q2 24
1.37×
Q1 24
1.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
PDLB
PDLB
Operating Cash FlowLast quarter
$-13.6M
$55.6M
Free Cash FlowOCF − Capex
$54.6M
FCF MarginFCF / Revenue
173.9%
Capex IntensityCapex / Revenue
3.1%
Cash ConversionOCF / Net Profit
5.48×
TTM Free Cash FlowTrailing 4 quarters
$74.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
PDLB
PDLB
Q4 25
$55.6M
Q3 25
$-13.6M
$1.4M
Q2 25
$-27.4M
$6.2M
Q1 25
$-48.0M
$13.1M
Q4 24
$7.2M
Q3 24
$-58.9M
$-14.6M
Q2 24
$-53.5M
$-2.6M
Q1 24
$-62.3M
$1.5M
Free Cash Flow
GERN
GERN
PDLB
PDLB
Q4 25
$54.6M
Q3 25
$786.0K
Q2 25
$5.9M
Q1 25
$12.9M
Q4 24
$4.5M
Q3 24
$-15.0M
Q2 24
$-53.7M
$-2.6M
Q1 24
$-62.9M
$-315.0K
FCF Margin
GERN
GERN
PDLB
PDLB
Q4 25
173.9%
Q3 25
2.9%
Q2 25
22.4%
Q1 25
52.6%
Q4 24
19.7%
Q3 24
-74.1%
Q2 24
-6086.6%
-13.0%
Q1 24
-20680.3%
-1.5%
Capex Intensity
GERN
GERN
PDLB
PDLB
Q4 25
3.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
0.6%
Q4 24
11.9%
Q3 24
0.0%
2.0%
Q2 24
23.4%
0.3%
Q1 24
202.3%
8.7%
Cash Conversion
GERN
GERN
PDLB
PDLB
Q4 25
5.48×
Q3 25
0.21×
Q2 25
1.01×
Q1 25
2.20×
Q4 24
2.46×
Q3 24
-5.99×
Q2 24
-0.80×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons